Phase I study of an active immunotherapy for asymptomatic phase Lymphoplasmacytic lymphoma with DNA vaccines encoding antigen-chemokine fusion: study protocol

Phase I study of an active immunotherapy for asymptomatic phase Lymphoplasmacytic lymphoma with DNA vaccines encoding antigen-chemokine fusion: study protocol

Abstract Background There is now a renewed interest in cancer vaccines. Patients responding to immune checkpoint blockade usually bear tumors that are heavily infiltrated by T cells and express a high load of neoantigens, indicating that the immune system is involved in the therapeutic effect of the...

Full description

Bibliographic Details
Main Authors: Sheeba K. Thomas, Soung-chul Cha, D. Lynne Smith, Kun Hwa Kim, Sapna R. Parshottam, Sheetal Rao, Michael Popescu, Vincent Y. Lee, Sattva S. Neelapu, Larry W. Kwak
Format: Article
Language:English
Published: BMC 2018-02-01
Series:BMC Cancer
Subjects:
DNA vaccine
Personalized medicine
Lymphoma
Phase I
Idiotype
Immune response
Online Access:http://link.springer.com/article/10.1186/s12885-018-4094-2

Internet

http://link.springer.com/article/10.1186/s12885-018-4094-2

Similar Items